CRMD

CorMedix Inc.

4.40 USD
+0.01 (+0.23%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CorMedix Inc. stock is down -13.89% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 53.33% of the previous 14 June’s closed higher than May. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 May 13:48 20 Dec, 2024 6.00 CALL 175 273
09 May 14:06 20 Dec, 2024 7.00 CALL 200 264
09 May 15:03 20 Dec, 2024 7.00 CALL 300 264
10 May 18:29 17 May, 2024 5.00 PUT 1354 4091
29 May 19:07 20 Dec, 2024 6.00 CALL 500 631

About CorMedix Inc.

CorMedix Inc. focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings.